Annexe 3: article supplémentaire J Piret, E Drouot, G Boivin, C Pavillon Etude des mécanismes moléculaires de résistance du cytomégalovirus humain …, 2015 | | 2015 |
Antiviral drug resistance in herpesviruses J Piret, E Drouot, G Boivin Handbook of antimicrobial resistance, 32, 2017 | 5 | 2017 |
Antiviral drug resistance in herpesviruses other than cytomegalovirus J Piret, G Boivin Reviews in medical virology 24 (3), 186-218, 2014 | 182 | 2014 |
Artesunate Demonstrates in vitro Synergism with Several Antiviral Agents against Human Cytomegalovirus E Drouot, J Piret, G Boivin Antiviral therapy 21 (6), 535-539, 2016 | 46 | 2016 |
Characterization of multiple cytomegalovirus drug resistance mutations detected in a hematopoietic stem cell transplant recipient by recombinant phenotyping E Drouot, J Piret, MH Lebel, G Boivin Journal of clinical microbiology 52 (11), 4043-4046, 2014 | 33 | 2014 |
Contrasting Effects of W781V and W780V Mutations in Helix N of Herpes Simplex 3 Virus-1 and Human Cytomegalovirus DNA Polymerases 4 on Antiviral Drug Susceptibility 5 J Piret, N Goyette, BE Eckenroth, E Drouot, M Götte, G Boivin | | 2015 |
Contrasting effects of W781V and W780V mutations in helix N of herpes simplex virus 1 and human cytomegalovirus DNA polymerases on antiviral drug susceptibility J Piret, N Goyette, BE Eckenroth, E Drouot, M Götte, G Boivin Journal of Virology 89 (8), 4636-4644, 2015 | 15 | 2015 |
Novel method based on “en passant” mutagenesis coupled with a Gaussia luciferase reporter assay for studying the combined effects of human cytomegalovirus mutations E Drouot, J Piret, G Boivin Journal of clinical microbiology 51 (10), 3216-3224, 2013 | 37 | 2013 |